Activation of chronic inflammation and comorbidity in end-stage renal disease patients treated with continuous ambulatory peritoneal dialysis.
DOI:
https://doi.org/10.26641/2307-0404.2020.2.206381Ключевые слова:
chronic kidney disease, continuous ambulatory peritoneal dialysis, рro-inflammatory cytokines, comorbidity, mortalityАннотация
The aim of the work was to determine the blood serum pro-inflammatory cytokine profile and to study their relationship with comorbidity and mortality in end-stage renal disease (ESRD) patients treated with continuous ambulatory peritoneal dialysis (CAPD). Ninety three ESRD patients treated with CAPD during 2012-2019 were included in the cohort prospective open study. The study was conducted in two stages. At the first stage, the determination of TNF-α and IL-6 levels was conducted and study of comorbidity, its quantitative assessment, baseline clinical and laboratory parameters was made. A modified polymorbidity index (MPI) which determined the quantitative assessment of comorbidity was calculated as the number of diseases per one patient excluding ESRD and its reasons. At the second stage, considering the baseline values of the studied cytokines, a prospective study of the dynamics of the prevalence of comorbid pathology, the value of MPI and mortality rate was carried out. The average duration of prospective follow-up was 26.4±6.8 months. Serum cytokines levels were determined by ELISA. Statistical analysis was performed by using "MedCalc", version 19.1.7. (Ostend, Belgium). Serum levels of TNF-α and IL-6 were significantly higher in PD-patients with 5 or more comorbid diseases. Levels of TNF-α>13.0 pg/ml have a negative effect on the dynamics of prevalence of heart failure (HF) and coronary heart disease (CHD), number of comorbid conditions in CAPD-patients. The proportion of the dead with a level of TNF-α>13.0 pg/ml was by three times higher, and deaths from cardiovascular events are almost by 10 times higher than patients who had a level of TNF-α≤13.0 pg/ml. Serum levels of IL-6>23.4 pg/ml are associated with a significant increase in number of comorbid conditions, prevalence of bacterial infections and overall and infectious mortality. Independent predictors of comorbidity and overall mortality in patients with ESRD who are treated with CAPD are serum levels of TNF-α, IL-6 and albumin. Serum levels of TNF-α and albumin are predictors of fatal cardiovascular events, and serum levels of IL-6 are predictors of fatal infectious events.
Библиографические ссылки
Antomonov MYu. [Mathematical processing and analysis of biomedical data]. Kyiv: Medinform; 2018:579.
Shifris IM. et al. [Нospital morbidity in patients with chronic kidney disease stage 5D]. Ukrainskyi Zhurnal Nefrolohii ta Dializu. 2014;4(44):31-40. Ukrainian. doi: https://doi.org/10.31450/ukrjnd.4(44).2014.02
Shifris IM, Dudar IO. [Comorbidity and survival of patients with chronic kidney disease of 5D stage]. Ukrainskyi Zhurnal Nefrolohii ta Dializu. 2015;4(48):30-39. Ukr. doi: https://doi.org/10.31450/ukrjnd.4(48).2015.06
Liu YL, Liu JH, Wang IK, et al. Association of inflammatory cytokines with mortality in peritoneal dialysis patients. Biomedicine (Taipei). 2017;7(1):1. doi: https://doi.org/10.1051/bmdcn/2017070101
Carrero JJ, Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol. 2009;4(Suppl 1):S49-S55. doi: https://doi.org/10.1111/sdi.12686
Lee J.-K, et al. Differential association of proinflammatory cytokines with left ventricular diastolic dysfunction in subjects with and without continuous ambulatory peritoneal dialysis. NMCD. 2012;22(11):974-80. doi: https://doi.org/10.1016/j.numecd.2011.01.001
Eloueyk AK, Alameddine RY, Osta BA, Awad DM. Correlations between serum in-flammatory markers and comorbidities in patients with end-stage renal disease. J Taibah Univ Med Sc. 2019;14(6):547-52. doi: https://doi.org/10.1016/j.jtumed.2019.10.003
MedCalc Statistical Software version 19.1.7 MedCalc Software Ltd, Belgium: Ostend; 2020. Available from: https://www.medcalc.org
Nowak KL, Chonchol M. Doesinflammation affect outcomes in dialysis patients? Semin Dial. 2018;31:388-97. doi: https://doi.org/10.1111/sdi.12686
Shymova AU, Shifris IM, Korol LV, Dudar ІО. Nutritional Status and Indicators of Oxidative Stress among End-Stage Renal Disease Patients Treated with Continuous Ambulatory Peritoneal Dialysis. Prensa Med Argent. 2020;106(2):1-5. Available from: https://www.scholarsliterature.com/journals/la-prensa-medica/current-issue
Stepanova N, Korol L, Burdeyna O. Oxidative Stress in Peritoneal Dialysis Patients: Association with the Dialysis Adequacy and Technique Survival. Indian J Nephrol. 2019;29:309-16. doi: https://doi.org/10.4103/ijn.IJN_242_18
Eunjung Kang, et al. Tumor necrosis factor α is a risk factor for infection in peritoneal dialysis patients. Korean J Intern Med. 2016;31(4):722-9. doi: https://doi.org/10.3904/kjim.2015.230
Загрузки
Как цитировать
Выпуск
Раздел
Лицензия
Copyright (c) 2020 Medicni perspektivi (Medical perspectives)
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
